Navigation Links
UCR cell biologist co-leads joint international conference on wound healing
Date:4/11/2008

t care, how to incorporate advanced therapeutic approaches in the field of wound care, as well as how to appreciate the many disciplines that are involved in caring for patients with wound problems.

Comprising educational sessions, meetings, interactive events, and social gatherings, the conference targets physicians, nurses, physical therapists, researchers, podiatrists, dieticians, and members of industry involved in wound healing or wound care issues.

This is the second year the Wound Healing Society is combining forces with the Symposium on Advanced Wound Care to deliver the latest in bench research results as well as the latest clinical advances in the field, said Dr. Paul Liu, chief of surgery at Roger Williams Medical Center, Providence, R.I., and a co-chair of the program committee for the Wound Healing Society. This meeting gathers several thousand of the worlds top care providers and researchers with expertise in difficult wounds. We anticipate clinical outcomes, and hence our patients lives, to be improved as a result.

The conference also will host poster sessions on April 25-26. On April 26, the Wound Healing Society will present the Young Investigators Award at its business meeting to a young investigator for outstanding achievement in clinical and laboratory research.

Registration for the conference costs $450 for physicians and $400 for other wound-care clinicians. Day passes cost $200. Students are eligible for a $100 discount on their registration. Reporters interested in covering the conference can attend it at no charge, simply by showing their media credentials.

The 21st Annual Symposium on Advanced Wound Care and The Wound Healing Society Meeting is funded largely by registration fees and membership dues.

The annual Symposium on Advanced Wound Care is the largest gathering of multidisciplinary wound care clinicians in the United States. Th
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Boston College biologists build a better mouse model for cancer research
2. Biologists Discover How Dengue Virus Matures
3. Stanford biologist awarded 2008 Sophie Prize in Norway
4. New book by UCR biologist discusses 12 diseases that impacted humanity
5. Joint Commission Alert: Prevent Pediatric Medication Errors
6. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
7. Stella Mora Henry to Present The Eldercare Handbook at Aging in America Joint Conference of National Council on Aging & The American Society on Aging March 27-29
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. Health Plan and Preferred Provider Network Communities Issue Joint Statement on Passage of Healthcare Simplification Act
10. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
11. The Joint Commission Urges Development of a National Performance Measurement Data Strategy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... ,, NEWORLEANS,Nov.23/PRNewswire/--Thanksgiv...#174;.Stronginitstradition,theClassicrepresentsthe...thanagameforthecityofNewOrleansandthoseinattendanc...GCWasche,thisisachanceforsomedowntimebeforetheywor..., Aftertwoyearsofconstruction,PettyOfficerClaud...
(Date:11/23/2009)... , Animal studies suggest that adding flaxseed oi...s in post-menopausal women and women with diabetes...ternational Journal of Food Safety, Nutrition and ...e National Research Center, in Cairo, Egypt, have ...evaluated how flaxseed oil in the diet might delay...
(Date:11/23/2009)... , Since 1996, crop plants genetically modified t...tain insects, yet safe for people, have been plant...e popularity of these Bt crops, named after the ba... ability to kill some major pests, allowing farmer...y reducing insecticide sprays. , However, since ...
(Date:11/23/2009)... Adding drug to chemo regimen may improve patient... Nov. 23 (HealthDay News) -- A new combination dru...advanced biliary-tract cancers, researchers say. ,...tal Cancer Center in Boston found that survival an...mab (Avastin), an angiogenesis inhibitor that has ...
(Date:11/23/2009)... HIV patients who have it take longer to get sick...hDay News) -- Scientists report that a genetic var...ease progression in HIV-infected patients. , ...ears longer to develop AIDS and die of complicatio...ors that vary across individuals that make a perso...
Breaking Medicine News(10 mins):Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2
...s that getting hospitals conscious about quality o...ts dying in that hospital. 26 percent fewer p...ttack when hospitals used quality-improvement // ...steps included a checklist that doctors, nurses an...
...boratories Thursday announced it had entered a co-...enmark-based Rheoscience A/S for the joint develop...the pact, Rheoscience will fund all costs associat... will pay Rheoscience a pre-determined amount towa...
... and team from the Institute of Tropical Medicine ...al AIDS, in which they have said that the HIV viru...iplication rate and is now more sensitive to anti-...ollected during 2002-03. The researchers compared ...
...on form of thalassaemia disease may not require bl...oglobin E ? thalassaemia—the commonest form of sev...managed without transfusion in many patients, sugg...es of donated blood—a scarce resource in many coun...
...ein has helped bald mice to get fur on the body, s... Catherine C. Thompson and colleagues at Johns...nd studied a gene known as Hairless, which encodes...rmal. But once hair is shed, it does not grow back...
...ss is considering whether to temporarily ban the E...man tests to determine whether a pesticide should ... decide whether to place a one year moratorium on ...es approved by the agency for marketing. The...
Other Medicine News:Health News:Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru 2Health News:US Senate Votes against Testing of Pesticide on Humans 2
(Date:11/23/2009)..., IRVINE,Calif.,Nov.23/PRNewswire/--AdvancedSte...ventionsolutionprovider,announcedtodaytheacquisiti...,aprivatelyhelddeveloperofinnovativedisinfectionpr...infections.Termsoftheacquisitionwerenotdisclosed. ...eadecontaminationtechnologythatprovidesdisinfectio...
(Date:11/20/2009)... , BOSTON, Nov. 20 The Uni... upheld an earlier District Court ruling yesterday...ge Wholesale Price (AWP) pharmaceutical litigation... (Logo: http://www.newscom.com/cgi-bin/prnh/20080...ment that awarded consumers who purchased the phar...
(Date:11/20/2009)... , LOUISVILLE, Ky., Nov. 20 /PRNewswire/ -...tigators (NADDI) today announced a new initiative ...rsor Log Exchange (NPLEx) is a multi-state electro...tions on over-the-counter (OTC) medicines containi...le. The technology for NPLEx is based on a system...
Breaking Medicine Technology:ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 1KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 4Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 1Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 1SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 3SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 4
...esented on Valopicitabine Combined,with an Investi...il 12, 2007 /PRNewswire-FirstCall/ --,Idenix Pharm...phase,IIb studies of the novel combination of valo...a (Pegasys(R)) in both treatment-naive,and treatme...e-1,strain of the hepatitis C virus (HCV). These d...
...osts of eradicating,poliomyelitis from the remaini...m, are much lower than the long term costs of tryi...a recently developed,monovalent vaccine is almost ...litis than an existing trivalent vaccine. These ar...d in an upcoming,issue of The Lancet. , Both Artic...
Other Medicine Technology:Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: